FabRx

FabRx is developing better medicines using patented 3D printing technology to enable medical treatments to be personalised to the individual needs of each patient (in terms of dosage, shape, size and dose combinations) for production on site in pharmacies or clinical trials units.

HEADQUARTERS
FabRx Ltd
29-39 Brunswick Square
London
WC1N 1AX
United Kingdom

Phone / Contact

T: +44 745 488 7793
E: [email protected]

Connect

FabRx is developing better medicines using patented 3D printing technology to enable medical treatments to be personalised to the individual needs of each patient (in terms of dosage, shape, size and dose combinations) for production on site in pharmacies or clinical trials units.

FabRx was spun out from University College London (UCL) in 2014.

Articles by FabRx

Anna Kirstine Jørgensen

3D PRINTING: THE FUTURE OF PERSONALISED MEDICINES

Anna Kirstine Jørgensen, Dr Abdul Basit along with Dr Alvaro Goyanes, discuss the role of 3D printing in shaping the future of personalised medication, and explain how FABRX’s two pharmaceutical 3D printers can help unlock its potential – extending even beyond Earth.

Sarah Trenfield

INNOVATIONS IN 3D PRINTED PHARMACEUTICALS

Sarah Trenfield, Abdul Basit and Alvaro Goyanes discuss the latest innovations in 3D printed pharmaceuticals.

Sarah Trenfield

PERSONALISING DRUG PRODUCTS USING 3D PRINTING

Sarah Trenfield and Abdul Basit look at the potential applications of 3D-printing technology to create personalised drug therapies in fields such as multiple drug therapy and paediatric/geriatric care and introduce FabRx’s 3D-printing system, which can produce formulations to suit a variety of situations.

Top